Concurrent advanced HIV disease and viral load suppression in a high-burden setting: Findings from the 2015-6 ZIMPHIA survey.
Shirish BalachandraJ H RogersL RuangtragoolE RadinGodfrey N MusukaI ObohoH PaulinB ParekhS BirhanuK C TakarindaA HakimT ApolloPublished in: PloS one (2020)
The percentage of PLHIV with AD and VLS illustrates the conundrum of decreased support for CD4 monitoring, as these patients may not receive appropriate clinical services for advanced HIV disease. In high-prevalence settings such as Zimbabwe, CD4 monitoring support warrants further consideration to differentiate care appropriately for the most vulnerable PLHIV. Males may need to be prioritized, given their over-representation in this sub-population.
Keyphrases
- hiv testing
- antiretroviral therapy
- hiv positive
- hiv infected
- healthcare
- human immunodeficiency virus
- hepatitis c virus
- end stage renal disease
- newly diagnosed
- ejection fraction
- risk factors
- palliative care
- primary care
- prognostic factors
- quality improvement
- mental health
- radiation therapy
- south africa
- chronic pain
- patient reported outcomes